Shenzhen Glory Medical Co.,Ltd.

Sümbol: 002551.SZ

SHZ

3.25

CNY

Turuhind täna

-16.6251
P/E suhe
0.6657
PEG suhe
2.75B
MRK Cap
0.00%
DIV tootlus

Shenzhen Glory Medical Co.,Ltd. (002551-SZ) Finantsaruanded

Q: Mis on Shenzhen Glory Medical Co.,Ltd. (002551.SZ) koguvara?

Shenzhen Glory Medical Co.,Ltd. (002551.SZ) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Shenzhen Glory Medical Co.,Ltd. (002551.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 1100.394 M, mis on 0.158 % gowth. Kogu perioodi keskmine brutokasum on 277.046 M, mis on 0.142 %. Keskmine brutokasumi suhtarv on 0.291 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.546 %, mis on võrdne 0.057 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Shenzhen Glory Medical Co.,Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.077. Käibevara valdkonnas on 002551.SZ aruandlusvaluutas 1822.663. Märkimisväärne osa neist varadest, täpsemalt 818.199, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.111%. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 269.544 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.125%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 2614.169 aruandlusvaluutas. Selle aspekti aastane muutus on -0.052%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 611.007, varude hind on 371.55 ja firmaväärtus 1.43, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 280.36.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
balance-sheet.row.cash-and-short-term-investments	3585.05	818.2	920.1	1088.9	1264.3	1062.7	460.3	763.9	523.9	385.9	558.1	650.3	890.6	879.8	84.7	63.2	46.2	44.2
balance-sheet.row.short-term-investments	1239.9	327.9	434.9	292.5	121.1	295.4	15	-197.9	-143.3	0	-164.3	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	2831.97	611	653.9	871.2	904.1	1005.4	1173	1135.4	1309	1059	701.1	514.8	396.6	217.2	138.7	124.3	127.5	95.3
balance-sheet.row.inventory	1558.23	371.5	416.8	375.9	343.7	302.9	254.5	360.9	327	299.1	332.9	293.5	65.8	41.9	62.9	31.9	28.1	17.4
balance-sheet.row.other-current-assets	409.81	21.9	37.4	57.4	99	111.7	133.6	159.5	188.3	316	72.6	18.8	-36.9	-13	-10.1	-21.4	-29.2	-27.5
balance-sheet.row.total-current-assets	8137.23	1822.7	2028.2	2393.4	2611.1	2482.7	2021.4	2419.6	2348.3	2060	1664.7	1477.4	1316.1	1125.9	276.1	198	172.6	129.4
balance-sheet.row.property-plant-equipment-net	2001.82	488.8	556	637.6	785.1	987.8	921.3	773.1	470.1	390.7	319.8	341.1	141.9	135.3	164.4	177.4	107.6	67.5
balance-sheet.row.goodwill	27.57	1.4	12.4	68.6	68.6	149.4	149.4	156.5	153.2	153.2	4	4	0	0	0	0	0.7	0
balance-sheet.row.intangible-assets	1099.93	280.4	510	275.6	217.2	233.6	235.2	236.5	241.7	163	151.4	61.1	11.9	12.1	12.4	12.7	13	13.2
balance-sheet.row.goodwill-and-intangible-assets	1127.5	281.8	522.4	344.2	285.8	383	384.6	392.9	394.9	316.2	155.4	65.1	11.9	12.1	12.4	12.7	13.7	13.2
balance-sheet.row.long-term-investments	-434.24	-194.7	-288.1	90.1	110.9	-278.3	6	226	804	0	172.3	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	356.29	103.9	137.4	93.1	86.1	76.6	53.2	42	39.5	31.1	26.8	15	4.4	2.8	2.6	2	2.1	0.5
balance-sheet.row.other-non-current-assets	5026.85	1429.3	1304.6	1414.8	1182.3	1068.2	718.1	456.8	1.5	160.4	17.5	120.6	49.1	52.3	33.1	12.9	22.2	0
balance-sheet.row.total-non-current-assets	8078.22	2109.1	2232.3	2579.8	2450.2	2237.3	2083.2	1890.8	1709.9	898.3	691.8	541.7	207.3	202.5	212.5	205	145.5	81.3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	16215.46	3931.7	4260.5	4973.2	5061.3	4720	4104.6	4310.4	4058.2	2958.3	2356.5	2019.2	1523.4	1328.4	488.6	403	318.1	210.7
balance-sheet.row.account-payables	1419.65	381.9	380	447.1	466.9	641.3	697.9	890	892.7	592.3	459.5	339.5	126	42.2	41.7	32.4	23.4	12.4
balance-sheet.row.short-term-debt	71.74	21.1	41.5	61.1	178.7	108.8	150.5	177.4	213.7	249.5	85.5	71.2	6.2	6.9	22.6	2.3	7.6	12.6
balance-sheet.row.tax-payables	235.77	73.8	81.2	97.8	80.9	97.8	129.5	150.3	107.2	97.1	66.1	40.2	27.5	15.3	10.3	7.7	6.3	5.4
balance-sheet.row.long-term-debt-total	1106.62	269.5	290.6	331.1	301.2	829	35.6	43	84.6	61	32.5	5.5	0	0	16.1	41.1	36.9	39.2
Deferred Revenue Non Current	244.94	80.4	84.3	75	76.3	72.5	73.2	80.7	84.4	86.9	25.7	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0.67	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	515.54	24.2	237.1	7.5	5.1	64.5	238.2	71.7	178.3	105.4	130	87.9	87.5	44.6	93.5	77.8	52	31.8
balance-sheet.row.total-non-current-liabilities	1443.15	354.2	379	417.4	377.4	901.8	110.9	129.3	337.1	171.3	82.3	42.3	25	21	35.7	46.9	43.1	44.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	4829.33	1184	1261.2	1526.8	1415.9	1903.9	1327	1637.2	1887.3	1376.9	899.6	684.2	303.8	147.8	212.6	173.8	145.9	127.7
balance-sheet.row.preferred-stock	126.64	59.5	65.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	3379.16	844.8	844.8	844.7	820.3	706	705.9	706	444.1	435.5	362.7	276.8	184.5	123	61.5	61.5	39.5	31.9
balance-sheet.row.retained-earnings	2105.02	429.8	578.7	829.7	772.1	665.3	669.3	621.3	496.7	382.7	305.7	237.2	203.8	173	147.9	103.5	67	44.4
balance-sheet.row.accumulated-other-comprehensive-income-loss	1074.15	-59.5	-65.2	42.5	68.7	83.7	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	4092.28	1339.6	1333.6	1403.8	1320.4	881.6	945.5	924.1	823.4	612.1	695.5	736.4	825.2	883.8	65.9	63.9	63.5	5.5
balance-sheet.row.total-stockholders-equity	10777.25	2614.2	2757.1	3120.7	2981.3	2336.6	2320.7	2251.4	1764.2	1430.4	1364	1250.4	1213.5	1179.7	275.3	228.9	170	81.8
balance-sheet.row.total-liabilities-and-stockholders-equity	16215.46	3931.7	4260.5	4973.2	5061.3	4720	4104.6	4310.4	4058.2	2958.3	2356.5	2019.2	1523.4	1328.4	488.6	403	318.1	210.7
balance-sheet.row.minority-interest	608.88	133.6	242.2	325.7	664.1	479.5	456.9	421.8	406.8	151	92.8	84.6	6.2	0.9	0.7	0.3	2.2	1.2
balance-sheet.row.total-equity	11386.13	2747.8	2999.3	3446.4	3645.4	2816.1	2777.6	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	16215.46	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	805.66	133.1	146.8	382.6	232	17.1	21	28	660.7	8.1	8	7.8	0.1	0	0	0	0	0
balance-sheet.row.total-debt	1178.36	290.6	332.1	392.2	479.9	937.9	186.2	220.3	298.3	310.6	117.9	76.7	6.2	6.9	38.7	43.3	44.5	51.8
balance-sheet.row.net-debt	-1166.79	-199.7	-153.2	-404.2	-663.4	170.6	-274.1	-543.5	-225.6	-75.4	-440.1	-573.6	-884.4	-872.9	-46	-19.9	-1.7	7.5

Rahavoogude aruanne

Shenzhen Glory Medical Co.,Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab -1.624 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.006 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -176847492.650. See on -0.686 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 125, 11.72, -88.82, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -163.95 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 61.68, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
cash-flows.row.net-income	-142.04	-327.9	88	369.9	76.4	134.7	189.2	136.3	143.5	111	77.5	59.6	44.3	46.8	39.5	24.6	22.1
cash-flows.row.depreciation-and-amortization	37.4	125	76.7	55.1	39.6	32	30.4	29.6	27.5	24.1	13.4	11.8	11.5	10	3.7	3	1.9
cash-flows.row.deferred-income-tax	0	-44.4	-1.2	-1.1	-25.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	44.4	1.2	1.1	25.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	37.9	-90.4	57.9	30.6	-57.9	-226.7	-19.4	16.1	-50.4	-190.4	-201.9	-58.1	-117.9	-7	15.1	-35.3	0
cash-flows.row.account-receivables	29.17	156.3	49.6	116.2	183.4	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	8.73	-55.9	-38.6	-41	-49.1	106.3	-34.7	-27.9	40.1	-40.4	-26.3	-23.9	21	-31.2	-3.8	-10.7	23.8
cash-flows.row.account-payables	0	-146.4	48.1	-43.5	-167	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-44.4	-1.2	-1.1	-25.1	-333	15.3	44.1	-90.5	-150	-175.6	-34.2	-138.9	24.2	18.9	-24.6	-23.8
cash-flows.row.other-non-cash-items	-8.88	389.7	20	41.9	81.7	102.2	35.2	99.3	97	41.3	26.4	18.4	5.6	1.3	-0.2	4	1.5
cash-flows.row.net-cash-provided-by-operating-activities	-162.73	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-48.06	-57.3	-430	-254.2	-254.6	-357.3	-345	-141.8	-83.8	-77	-84.6	-12.8	-8.5	-15.4	-82.5	-39.3	-40.1
cash-flows.row.acquisitions-net	1.23	1.5	0.5	-67.1	255	447.3	29.9	0	-114.1	-17.5	-41.5	0	0	0	0	-0.7	0
cash-flows.row.purchases-of-investments	-814.88	-865.4	-1221	-295.2	-817	-199	-685.2	-509.7	0	-37.7	0	-0.1	0	0	-4.2	0	0
cash-flows.row.sales-maturities-of-investments	863.05	732.6	1087.2	473.3	541	237.9	777.5	127.9	6.5	17.5	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	84.27	11.7	-0.1	-5.4	-254.6	-357.3	1.2	35	-256	-3.1	0	0	0.2	14.6	2.7	0	0
cash-flows.row.net-cash-used-for-investing-activites	85.43	-176.8	-563.4	-148.6	-530.2	-228.3	-221.6	-488.6	-447.4	-117.9	-126.1	-12.9	-8.3	-0.9	-84	-39.9	-40.1
cash-flows.row.debt-repayment	-103.35	-88.8	-248.4	-204.2	-358.5	-814.1	-1075.3	-1016.8	-626.2	-101.3	-31.6	-19.8	-31.8	-29.6	-23.4	-7.3	-2.3
cash-flows.row.common-stock-issued	0.19	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-0.19	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-57.3	-164	-30.3	-49.8	-74.2	-84.5	-35.2	-18.2	-50.1	-34.3	-42.8	-27.5	-16.9	-2.5	-3	-3.2	-2.3
cash-flows.row.other-financing-activites	52.56	61.7	287	338.9	1084.6	787.1	1322.3	1354.2	719.5	131.9	30	23.1	876.7	26.3	41.3	54.5	47.4
cash-flows.row.net-cash-used-provided-by-financing-activities	-45.97	-191.1	8.3	84.9	652	-111.4	211.8	319.2	43.2	-3.8	-44.3	-24.2	828	-5.8	14.8	44	42.8
cash-flows.row.effect-of-forex-changes-on-cash	-8.8	6.1	4.7	-20.3	2	-0.1	-7	2.8	-1.2	-0.8	-1.6	-0.4	0	-0.2	0	0.1	0
cash-flows.row.net-change-in-cash	-132.06	-265.4	-307.7	413.6	263.6	-297.6	218.6	114.8	-187.9	-136.5	-256.6	-5.6	763.2	44.2	-11.1	0.5	28.3
cash-flows.row.cash-at-end-of-period	1983.54	387.2	652.6	960.4	546.8	283.2	580.8	362.2	247.4	435.3	571.8	828.4	834.1	70.9	26.8	37.8	37.3
cash-flows.row.cash-at-beginning-of-period	2115.6	652.6	960.4	546.8	283.2	580.8	362.2	247.4	435.3	571.8	828.4	834.1	70.9	26.8	37.8	37.3	9
cash-flows.row.operating-cash-flow	-162.73	96.5	242.6	497.5	139.9	42.2	235.4	281.4	217.6	-14.1	-84.6	31.7	-56.5	51	58.1	-3.7	25.6
cash-flows.row.capital-expenditure	-48.06	-57.3	-430	-254.2	-254.6	-357.3	-345	-141.8	-83.8	-77	-84.6	-12.8	-8.5	-15.4	-82.5	-39.3	-40.1
cash-flows.row.free-cash-flow	-210.79	39.2	-187.4	243.3	-114.7	-315.1	-109.6	139.6	133.8	-91.1	-169.2	19	-65.1	35.6	-24.3	-42.9	-14.5

Kasumiaruande rida

Shenzhen Glory Medical Co.,Ltd. tulud muutusid võrreldes eelmise perioodiga -0.065%. 002551.SZ brutokasum on teatatud 197.6. Ettevõtte tegevuskulud on 217.49, mille muutus võrreldes eelmise aastaga on -4.785%. Kulud amortisatsioonikulud on 125, mis on -0.233% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 217.49, mis näitab -4.785% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -154.184% kasvu võrreldes eelmise aastaga. Tegevustulu on -121.22, mis näitab -154.184% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.546%. Eelmise aasta puhaskasum oli -148.89.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
income-statement-row.row.total-revenue	1159.63	1192.9	1275.7	1790.3	2267.3	1530.8	1630.4	2006.5	1946	1666.3	1166.8	730.9	421.3	348.4	270	208.5	138.1	116.4
income-statement-row.row.cost-of-revenue	972.72	995.3	1053.8	1427.4	1572.6	1201	1228.5	1533.7	1471.1	1229.6	836.5	508.4	260.8	243.1	162.7	122.3	79.5	70.7
income-statement-row.row.gross-profit	186.91	197.6	221.9	362.9	694.7	329.8	402	472.7	475	436.7	330.3	222.5	160.6	105.3	107.3	86.2	58.5	45.6
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	40.19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	35.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	18.79	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-6.91	-6.4	115.4	100.6	121.4	59	30.1	-0.1	7.8	4.5	2.5	7.3	3.3	1.7	0.7	0.5	-0.2	1.3
income-statement-row.row.operating-expenses	187.94	217.5	228.4	267.9	311.5	203.2	197.4	228.3	245.1	238.8	176.2	127.3	89.9	68.2	49.1	39.7	26.1	20.1
income-statement-row.row.cost-and-expenses	1160.66	1212.8	1282.3	1695.3	1884	1404.2	1425.9	1762	1716.2	1468.4	1012.7	635.7	350.7	311.4	211.8	162	105.6	90.8
income-statement-row.row.interest-income	11.44	8.7	6.9	5.2	8.7	7.7	5.5	7.3	7	8.8	17.5	21.7	17	18.4	1.5	0.2	0.2	0.1
income-statement-row.row.interest-expense	1.74	2	4.4	7.2	17	12.1	11.4	12	19	14.2	10.2	6.4	2.9	0.5	2.3	2.2	0.5	0.5
income-statement-row.row.selling-and-marketing-expenses	18.79	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	13.28	-6.4	-385.2	-37.7	-1.8	-70.2	-51.6	-19.2	-67.7	-25.6	-20.7	0.6	1.9	15	-0.4	0.7	-3.9	-0.8
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-6.91	-6.4	115.4	100.6	121.4	59	30.1	-0.1	7.8	4.5	2.5	7.3	3.3	1.7	0.7	0.5	-0.2	1.3
income-statement-row.row.total-operating-expenses	13.28	-6.4	-385.2	-37.7	-1.8	-70.2	-51.6	-19.2	-67.7	-25.6	-20.7	0.6	1.9	15	-0.4	0.7	-3.9	-0.8
income-statement-row.row.interest-expense	1.74	2	4.4	7.2	17	12.1	11.4	12	19	14.2	10.2	6.4	2.9	0.5	2.3	2.2	0.5	0.5
income-statement-row.row.depreciation-and-amortization	141.73	95.9	125	76.7	67.9	39.6	32	30.4	29.6	27.5	24.1	13.4	11.8	11.5	10	3.7	3	1.9
income-statement-row.row.ebitda-caps	14.82	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-126.91	-121.2	0.8	126.7	370.3	141	122.8	225.4	154.4	167.8	131.3	88.6	69.2	50.3	57.1	46.7	28.8	23.4
income-statement-row.row.income-before-tax	-113.63	-127.6	-384.4	89.1	368.5	70.8	153	225.3	162.2	172.3	133.4	95.8	72.5	52	57.8	47.2	28.6	24.7
income-statement-row.row.income-tax-expense	36.6	33.2	-56.5	1	-1.5	-5.6	18.2	36.1	25.8	28.9	22.4	18.3	12.9	7.7	11.1	7.7	4	2.6
income-statement-row.row.net-income	-142.04	-148.9	-327.9	88	369.9	59.8	97.7	175.2	114.2	119.1	102.2	73.8	58.3	44.2	46.4	39.9	24.1	22